The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

Yi Zhang, Anieta M. Sieuwerts, Michelle McGreevy, Graham Casey, Tanja Cufer, Angelo Paradiso, Nadia Harbeck, Paul N. Span, David G. Hicks, Joseph Crowe, Raymond R. Tubbs, G. Thomas Budd, Joanne Lyons, Fred C G J Sweep, Manfred Schmitt, Francesco Schittulli, Rastko Golouh, Dmitri Talantov, Yixin Wang, John A. Foekens

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences